Celsure: new technology to prevent vaccine wastage during transportation2 min read . Updated: 30 Aug 2017, 04:44 PM IST
Pluss Advanced Technologies has come up with India's first patent pending product Celsure for transporting medicines
New Delhi: In a bid to prevent vaccine wastage during transportation, Pluss Advanced Technologies, a venture funded by Tata Capital Innovations Fund, has come up with India’s first patent pending product Celsure™ for transporting medicines.
After undergoing 200 trials, Celsure™ holds the potential to addresses the key challenges faced during transportation of medicines that lead to wastage of life-saving vaccines.
“It is the first solution which not only simplifies the complete packaging procedure but also gives precise temperature control for more than 70 hours even at ambient temperatures greater than 40 degrees Celsius. Shipments from India to Kenya by air have even endured for 152 hours," said Samit Jain, managing director of Pluss Advanced Technologies Pvt Ltd.
Celsure™ uses a combination of Phase Change Materials that store heat and cold along with a unique design to provide precise temperature control of 2-8 degrees Celsius. In fact, Celsure™ comes with a guarantee that the temperature will never be below 2.5 degrees Celsius.
“The traditional ice pack based solutions run a high risk of experiencing temperatures below 2 degrees Celsius. Celsure™ has been designed especially for Indian conditions where temperature crosses 40 degrees C in summers and winters are not really winters with most medicine hubs like Hyderabad, Mumbai and Bangalore not experiencing temperatures below 15 degrees C. Celsure™ works across all weathers with no change in packaging," Jain said.
Celsure™ gives temperature control for 72 hours even at a constant ambient temperature of 40 degrees C which challenges the status quo of ‘air shipments only’ for medicinal products, he said.
Celsure™ allows companies to transport medicines by road in a regular truck, leading to huge savings in freight costs. The technology also provides the unique advantage of not requirement of thawing or conditioning of ice packs at room temperature for 20-30 minutes before packing. “The packaging time has been reduced to just 5 minutes because of this feature and removed any chance of a human error," said Jain.
“Celsure™ has been able to provide all the above features at competitive price points. It is all set to bring a radical change in the vaccine cold chain logistics segment in India and other low and middle income countries. Indirectly, with proper vaccination, infant mortality will reduce thus even helping the world meet the sustainable development goals (SDG), “ he said.
According to World Health Organisation (WHO) data, over 25% vaccines go waste globally even before reaching the doctors and patients while many lose their efficacy by the time they are administered due to lack of a quality supply chain and logistics management system. This is posing a major challenge for the governments as well as public health agencies working to expand immunization coverage.